My Favorite Psychedelic Stocks: Part 1
Our resident Psychedelic Investor details five companies he thinks are in strong position to win the psychedelic medicine race.
Cybin
Psychedelic Business Spotlight – February 18
This week in psychedelic business news: Nova Mentis makes progress on autism; atai donates to MAPS; Cathie Wood eyes more psychedelic stocks.
Cybin Partners with The Chopra Foundation to Bring Awareness to the Benefits of Psychedelic-Based Therapies
“The need for new and more effective treatments across the mental health spectrum is more urgent today than ever,” says Dr. Deepak Chopra.
Psychedelic Business Spotlight – February 11
This week in psychedelic business news: Cybin scores another patent; another huge psychedelics conference heads to Miami; Core One Labs widens pipeline with another drug.
4 Tips for Investing in Psychedelic Stocks During a Market Downturn
Friendly advice for responsibly managing speculative bets on psychedelic stocks that may rise like a phoenix or burn to the ground.
Cybin Set to Measure Psychedelic Effects on the Brain Using Kernel Flow’s Revolutionary Technology
The technology may be more broadly used in the future for neuroscientific or physiological studies of brain activity during psychedelic use.
2021: A Year in Review for the Psychedelics Business
Our resident Psychedelic Investor looks back at some of this growing industry’s biggest moments and how they may shape the business in 2022.
Psychedelic Business Spotlight – December 17
This week in psychedelic business news: Cybin steps closer to a new patent; MindMed appoints new CEO; MAPS and Wesana Health resume negotiations.
Psychedelic Business Spotlight: December 3
This week in psychedelic business news: MAPS pioneers new funding structure; FDA green lights a Cybin study for Covid-19 distress; Compass Pathways gets new majority stakeholder.
Psychedelic Business Spotlight: November 26
This week in psychedelic business news: Compass Pathways files another patent; Seelos Therapeutics raises big money; Cybin makes psychedelic therapy more accessible in NYC.
End of content
End of content